Skip to main content

August 2022

academics

 

Clinical research courses

Multiple Openings at Centaur Pharmaceuticals - Walk in

In 1978, Centaur Pharmaceuticals, commenced pharmaceutical manufacturing operations in Mumbai and has now evolved into a vertically integrated pharmaceutical company. Centaur House, our corporate headquarters, is located in Mumbai, the commercial capital of India. Centaur has a strong matrix of capabilities across the pharmaceutical value chain including API, formulations, Contract Research and Manufacturing Services, Clinical Research, R&D, regulatory and marketing.

Johnson & Johnson looking for Area Safety Head

Caring for the world, one person at a time has inspired and united the people of Johnson & Johnson for over 125 years. We embrace research and science - bringing creative ideas, products and services to advance the health and well-being of people. Every day, our more than 130,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Walk in interview for M.Pharm, M.Sc, B.Pharm in OSD formulation at Aristo Pharmaceuticals Pvt. Ltd

Aristo started its operations in 1971 with a manufacturing plant at Aurangabad, marketing operations in Mumbai with a field force of just 30 personnel. Since then Aristo has come a long way... From a turnover of US 8500 dollar in 1971 to US 64 million dollar in year 2000. The last few years have seen us blazing new trails and setting new standards in the pharmaceutical industry. The company has a formidable position in the industry. Sound infrastructure and well-qualified human force have helped Aristo to accomplish this achievement.

Regulatory Affairs Senior Manager at Procter & Gamble Company

P&G was founded over 180 years ago as a simple soap and candle company. Today, we're the world’s largest consumer goods company and home to iconic, trusted brands that make life a little bit easier in small but meaningful ways. We've spanned three centuries thanks to three simple ideas: leadership, innovation and citizenship. The insight, innovation and passion of hardworking teams has helped us grow into a global company that is governed responsibly and ethically, that is open and transparent, and that supports good causes and protects the environment.

Walk in interview for M.Pharm, M.Sc, B.Pharm in Production, QC, QA, ARD Department at ANNORA Pharma

Established in 2016, ANNORA Pharma is committed to provide medicines with highest quality, safety and efficacy that meets the needs of the customers with applicable statutory and regulatory requirements.  Spread over in thirty-five acres land, our manufacturing facility close to the city of Hyderabad, India specializes in manufacturing of Tablets, Capsules, Pellets, Liquid Orals, Suppositories and Dry Powder Syrups catering to a diverse therapeutic range.

Microscopy reveals mechanism behind new CRISPR tool

New research from Cornell offers insights into a line of CRISPR systems, which could lead to promising antiviral and tissue engineering tools in animal and plants.

The research by Ailong Ke, the Robert J. Appel Professor of molecular biology and genetics in the College of Arts and Sciences, and Stan J.J. Brouns at Delft University of Technology in the Netherlands, focuses on a newly discovered CRISPR RNA-guided Caspase system, otherwise known as Craspase.

Universal Flu Vaccine Protects Against Variants of Both Influenza A and B Viruses : Researcher

A new universal flu vaccine protects against diverse variants of both influenza A and B viruses in mice, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

The researchers designed a single, universal influenza vaccine candidate with key cross-protective, less variable parts of the influenza A and B viruses: multi-neuraminidase protein subtypes known to be major antiviral drug targets and the universally conserved M2 ectodomain protein.

Nirmatrelvir effective in elder COVID-19 patients

Israel based scientists found out that the rates of hospitalization and death due to COVID-19 were significantly lower among those who received nirmatrelvir in patients 65 years of age or older.

At the beginning of the surge of the omicron variant in January 2022, the Israeli authorities decided to pursue two lines of defense to protect the vulnerable and high-risk populations from severe Covid-19: a second booster dose and antiviral therapy.

Dr Reddys Labs receives EIR from USFDA for Srikakulam based facility

Dr Reddys Labs has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the formulations manufacturing facility in Srikakulam, Andhra Pradesh.

USFDA had conducted an inspection on 7th July 2022 at formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh.

Bayer launches its blockbuster drug finerenone in India

Bayer launches its blockbuster drug finerenone to treat chronic kidney disease (CKD) associated with type-II diabetes in India.This drug will be available as brand name of Kerendia in India.

India is becoming the hub of diabetes and CKD is common in people with diabetes. Approximately 1 in 3 adults with diabetes has CKD. Both type 1 and type 2 diabetes can cause kidney disease. where, finerenone is used to treat CKD associated with type-II diabetes.